[1]
Yunhua, M. et al. 2020. Febuxostat Promoted Dissolution of Radiolucent Nephrolithiasis in Patients with Hyperuricemia. Urology Journal. 18, 01 (Apr. 2020), 41–46. DOI:https://doi.org/10.22037/uj.v18i01.5564.